Home Clinical Topics FDA allows marketing of first device to prevent migraine headaches

FDA allows marketing of first device to prevent migraine headaches

On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation device specifically authorized for use before the onset of pain. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here